Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Income tax effect of non-GAAP adjustments by Quarter
Income tax effect of non-GAAP adjustments ($M) ($M)
Gilead Sciences Income tax effect of non-GAAP adjustments: -$574M in Q2 2026, up 254.3% from a year earlier.
Where the Q2 2026 figure comes from
“|| Income tax effect of non-GAAP adjustments above | (574) | (162) | (631) | (316)”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-08-04) ↗
Reported in Form 8-K GAAP to Non-GAAP Reconciliation.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Gilead Sciences Income tax effect of non-GAAP adjustments ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-adj-tax
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.